In pancreatic cancer, a natural small molecule, astaxanthin, acts via the HIF-1α/STAT3 axis to mediate RRM2, regulating the gemcitabine-induced EMT phenotype [46]. Here, RRM2 is linked to familial pancreatic carcinoma.